Mitotic catastrophe and cancer drug resistance: A link that must to be broken

Drug Resistance Updates

Volumn 24, Issue , 2016, Pages 1-12

  Denisenko, Tatiana V ^a   Sorokina, Irina V ^a   Gogvadze, Vladimir ^a,b   Zhivotovsky, Boris ^a,b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Drug resistance; Genomic instability; Mitotic catastrophe

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER THERAPY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CHROMOSOMAL INSTABILITY; CHROMOSOME NUMBER; CHROMOSOME SEGREGATION; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; HUMAN; M PHASE CELL CYCLE CHECKPOINT; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NECROSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; POLYPLOIDY; PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR RESISTANCE; CELL CYCLE; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; MUTATION; NEOPLASMS; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; GENOMIC INSTABILITY; HUMANS; MUTATION; NEOPLASMS;

EID: 84949548631     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2015.11.002     Document Type: Article

References (124)

1. J. Atkinson, A.A. Kapralov, N. Yanamala, Y.Y. Tyurina, A.A. Amoscato, L. Pearce, J. Peterson, Z. Huang, J. Jiang, A.K. Samhan-Arias, A. Maeda, W. Feng, K. Wasserloos, N.A. Belikova, V.A. Tyurin, H. Wang, J. Fletcher, Y. Wang, I.I. Vlasova, J. Klein-Seetharaman, D.A. Stoyanovsky, H. Bayîr, B.R. Pitt, M.W. Epperly, J.S. Greenberger, and V.E. Kagan A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death Nat. Commun. 2 2011 497
2. Y. Aylon, D. Michael, A. Shmueli, N. Yabuta, H. Nojima, and M. Oren A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization Genes Dev. 20 2006 2687 2700
3. A. Azad, S. Jackson, C. Cullinane, A. Natoli, P.M. Neilsen, D.F. Callen, S.-M. Maira, W. Hackl, G.A. McArthur, and B. Solomon Inhibition of DNA-Dependent Protein Kinase Induces Accelerated Senescence in Irradiated Human Cancer Cells Mol. Cancer Res. 9 2011 1696 1707
4. J. Bartek, and J. Lukas DNA repair: damage alert Nature 421 2003 486 488
5. R. Basto, K. Brunk, T. Vinadogrova, N. Peel, A. Franz, A. Khodjakov, and J.W. Raff Centrosome amplification can initiate tumorigenesis in flies Cell 133 2008 1032 1042
6. S. Bonnet, S.L. Archer, J. Allalunis-Turner, A. Haromy, C. Beaulieu, R. Thompson, C.T. Lee, G.D. Lopaschuk, L. Puttagunta, S. Bonnet, G. Harry, K. Hashimoto, C.J. Porter, M.A. Andrade, B. Thebaud, and E.D. Michelakis A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth Cancer Cell 11 2007 37 51
7. T. Boveri Concerning the origin of malignant tumours by Theodor Boveri J. Cell Sci. 121 Suppl 1 2008 S1 S84 (translated and annotated by Henry Harris)
8. B.R. Brinkley Managing the centrosome numbers game: from chaos to stability in cancer cell division Trends Cell Biol. 11 2001 18 21
9. C.M. Caldwell, R.A. Green, and K.B. Kaplan APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice J. Cell Biol. 178 2007 1109 1120
10. M. Castedo, A. Coquelle, I. Vitale, S. Vivet, S. Mouhamad, S. Viaud, L. Zitvogel, and G. Kroemer Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis Ann. N. Y. Acad. Sci. 1090 2006 35 49
11. M. Castedo, J.L. Perfettini, T. Roumier, K. Yakushijin, D. Horne, R. Medema, and G. Kroemer The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe Oncogene 23 2004 4353 4361
12. J.Y. Chan A clinical overview of centrosome amplification in human cancers Int. J. Biol. Sci. 7 2011 1122 1144
13. G. Chatzinikolaou, I. Karakasilioti, and G.A. Garinis DNA damage and innate immunity: links and trade-offs Trends Immunol. 35 2014 429 435
14. J.P.H. Chow, R.Y.C. Poon, and H.T. Ma Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit Mol. Cell. Biol. 31 2011 1478 1491
15. K.A. Cimprich, and D. Cortez ATR: an essential regulator of genome integrity Nat. Rev. Mol. Cell Biol. 9 2008 616 627
16. M. Clemente-Ruiz, M. Muzzopappa, and M. Milán Tumor suppressor roles of CENP-E and Nsl1 in Drosophila epithelial tissues Cell Cycle 13 2014 1450 1455
17. L. Cornell, J.M. Munck, C. Alsinet, A. Villanueva, L. Ogle, C.E. Willoughby, D. Televantou, H.D. Thomas, J. Jackson, A.D. Burt, D. Newell, J. Rose, D.M. Manas, G.I. Shapiro, N.J. Curtin, and H.L. Reeves DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival Clin. Cancer Res. 21 2015 925 933
18. D. Crighton, S. Wilkinson, J. O'Prey, N. Syed, P. Smith, P.R. Harrison, M. Gasco, O. Garrone, T. Crook, and K.M. Ryan DRAM, a p53-induced modulator of autophagy, is critical for apoptosis Cell 126 2006 121 134
19. S.M. Da Silva, T. Moutinho-Santos, and C.E. Sunkel A tumor suppressor role of the Bub3 spindle checkpoint protein after apoptosis inhibition J. Cell Biol. 201 2013 385 393
20. Y. Dai, and S. Grant New insights into checkpoint kinase 1 in the DNA damage response signaling network Clin. Cancer Res. 16 2010 376 383
21. S. Daido, A. Yamamoto, K. Fujiwara, R. Sawaya, S. Kondo, and Y. Kondo Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy Cancer Res. 65 2005 4368 4375
22. W.B. Dalton, B. Yu, and V.W. Yang p53 suppresses structural chromosome instability after mitotic arrest in human cells Oncogene 29 2010 1929 1940
23. E.C. De Bruin, and J.P. Medema Apoptosis and non-apoptotic deaths in cancer development and treatment response Cancer Treat. Rev. 34 2008 737 749
24. N. Donnelly, and Z.A. Storchova Causes and consequences of protein folding stress in aneuploid cells Cell Cycle 14 2015 495 501
25. P. Duesberg, R. Li, A. Fabarius, and R. Hehlmann The chromosomal basis of cancer Cell. Oncol. 27 2005 293 318
26. U.S. Eggert, T.J. Mitchison, and C.M. Field Animal cytokinesis: from parts list to mechanisms Annu. Rev. Biochem. 75 2006 543 566
27. S. Ekman, J.E. Frödin, J. Harmenberg, A. Bergman, A. Hedlund, P. Dahg, C. Alvfors, B. Ståhl, S. Bergström, and M. Bergqvist Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma Acta Oncol. (Stockholm, Sweden) 50 2011 441 447
28. A.L. Gartel, and A.L. Tyner The role of the cyclin-dependent kinase inhibitor p21 in apoptosis Mol. Cancer Ther. 1 2002 639 649
29. K.E. Gascoigne, and S.S. Taylor How do anti-mitotic drugs kill cancer cells? J. Cell Sci. 122 2009 2579 2585
30. G. Gentric, V. Maillet, V. Paradis, D. Couton, A. L'Hermitte, G. Panasyuk, B. Fromenty, S. Celton-Morizur, and C. Desdouets Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease 125 2015 981 992
31. A. Glücksmann, and F.G. Spear The effect of gamma radiation on cells in vivo Br. J. Radiol. Part II 12 1939 486 499
32. V. Gogvadze, and B. Zhivotovsky Mitochondria - a bullseye in cancer therapy Mitochondrion 19 2014 1 2
33. N. Gonen, and Y.G. Assaraf Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance Drug Resist. Updat. 15 2012 183 210
34. D.J. Gordon, B. Resio, and D. Pellman Causes and consequences of aneuploidy in cancer Nat. Rev. Genet. 13 2012 189 203
35. V.G. Gorgoulis, L.V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R.A. Ditullio Jr., N.G. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, M. Herlyn, C. Kittas, and T.D. Halazonetis Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 434 2005 907 913
36. A. Groth, J. Lukas, E.A. Nigg, H.H.W. Silljé, C. Wernstedt, J. Bartek, and K. Hansen Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint EMBO J. 22 2003 1676 1687
37. J.S. Han, B. Vitre, D. Fachinetti, and D.W. Cleveland Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling Proc. Natl. Acad. Sci. USA 111 2014 4185 4193
38. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
39. M.E. Harley, L.A. Allan, H.S. Sanderson, and P.R. Clarke Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest EMBO J. 29 2010 2407 2420
40. J.W. Harper, and S.J. Elledge The DNA damage response: ten years after Mol. Cell 28 2007 739 745
41. L. Hewitt, A. Tighe, S. Santaguida, A.M. White, C.D. Jones, A. Musacchio, S. Green, and S.S. Taylor Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex J. Cell Biol. 190 2010 25 34
42. A.J. Holland, and D.W. Cleveland Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis Nat. Rev. Mol. Cell Biol. 10 2009 478 487
43. C. Holohan, S. van Schaeybroeck, D.B. Longley, and P.G. Johnston Cancer drug resistance: an evolving paradigm Nat. Rev. Cancer 13 2013 714 726
44. X. Huang Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. 2005 Humana Press Totowa USA
45. D. Huertas, M. Soler, J. Moreto, A. Villanueva, A. Martinez, A. Vidal, M. Charlton, D. Moffat, S. Patel, J. McDermott, J. Owen, D. Brotherton, D. Krige, S. Cuthill, and M. Esteller Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin Oncogene 31 2012 1408 1418
46. D. Huszar, M.E. Theoclitou, J. Skolnik, and R. Herbst Kinesin motor proteins as targets for cancer therapy Cancer Metastasis Rev. 28 2009 197 208
47. S.P. Jackson, and J. Bartek The DNA-damage response in human biology and disease Nature 461 2009 1071 1078
48. A. Janssen, G.J. Kops, and R.H. Medema Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells Proc. Natl. Acad. Sci. USA. 106 2009 19108 19113
49. A. Jazayeri, J. Falck, C. Lukas, J. Bartek, G.C. Smith, J. Lukas, and S.P. Jackson ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks Nat. Cell Biol. 8 2006 37 45
50. K. Jeganathan, L. Malureanu, D.J. Baker, S.C. Abraham, and J.M. van Deursen Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis J. Cell Biol. 179 2007 255 267
51. L. Jiang, M.K. Siu, O.G. Wong, K.F. Tam, X. Lu, E.W. Lam, H.Y. Ngan, X.F. Le, E.S. Wong, L.J. Monteiro, H.Y. Chan, and A.N. Cheung iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe Clin. Cancer Res. 17 2011 6924 6933
52. M.A. Kang, E.Y. So, A.L. Simons, D.R. Spitz, and T. Ouchi DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway Cell Death Dis. 3 2012 249
53. H. Karra, R. Pitkänen, M. Nykänen, K. Talvinen, T. Kuopio, M. Söderström, and P. Kronqvist Securin predicts aneuploidy and survival in breast cancer Histopathology 60 2012 586 596
54. T. Kato, Y. Daigo, M. Aragaki, K. Ishikawa, M. Sato, S. Kondo, and M. Kaji Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients Lung Cancer 74 2011 124 131
55. G.J. Kops, B.A. Weaver, and D.W. Cleveland On the road to cancer: aneuploidy and the mitotic checkpoint Nat. Rev. Cancer 5 2005 773 785
56. M. Kracikova, G. Akiri, A. George, R. Sachidanandam, and S.A. Aaronson A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis Cell Death Differ. 20 2013 576 588
57. M. Kwon, S.A. Godinho, N.S. Chandhok, N.J. Ganem, A. Azioune, M. Thery, and D. Pellman Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes Genes Dev. 22 2008 2189 2203
58. V. Labi, and M. Erlacher How cell death shapes cancer Cell Death Dis. 6 2015 1675
59. B.G. Lambrus, Y. Uetake, K.M. Clutario, V. Daggubati, M. Snyder, G. Sluder, and A.J. Holland P53 protects against genome instability following centriole duplication failure J. Cell Biol. 210 2015 63 77
60. P. Langerak, and P. Russell Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair Philos. Trans. R. Soc. Lond. B Biol. Sci. 366 2011 3562 3571
61. F. Lazzaro, M. Giannattasio, F. Puddu, M. Granata, A. Pellicioli, P. Plevani, and M. Muzi-Falconi Checkpoint mechanisms at the intersection between DNA damage and repair DNA Repair (Amst) 8 2009 1055 1067
62. S.M. Lens, E.E. Voest, and R.H. Medema Shared and separate functions of polo-like kinases and aurora kinases in cancer Nat. Rev. Cancer 10 2010 825 841
63. S. Liu, T. Sawada, S. Lee, W. Yu, G. Silverio, P. Alapatt, I. Millan, A. Shen, W. Saxton, T. Kanao, R. Takahashi, N. Hattori, Y. Imai, and B. Lu Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria PLoS Genet. 8 2012 1002537
64. Y.D. Livney, and Y.G. Assaraf Rationally designed nanovehicles to overcome cancer chemoresistance Adv. Drug Deliv. Rev. 65 2013 1716 1730
65. C.J. Lord, and A. Ashworth The DNA damage response and cancer therapy Nature 481 2012 287 294
66. H. Maiato, and E. Logarinho Mitotic spindle multipolarity without centrosome amplification Nat. Cell Biol. 16 2014 386 394
67. J. Majuelos-Melguizo, M.I. Rodríguez, L. López-Jiménez, J.M. Rodríguez-Vargas, J.M. Martí Martín-Consuegra, S. Serrano-Sáenz, J. Gavard, J.M. de Almodóvar, and F.J. Oliver PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma Oncotarget 6 2014 4790 4803
68. R.L. Margolis Tetraploidy and tumor development Cancer Cell. 8 2005 353 354
69. D. Maskey, S. Yousefi, I. Schmid, I. Zlobec, A. Perren, R. Friis, and H.U. Simon ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy Nat Commun. 4 2013 2130
70. C.H. McGowan Checking in on Cds1 (Chk2): a checkpoint kinase and tumor suppressor BioEssays 24 2002 502 511
71. S. Meunier, and I. Vernos Microtubule assembly during mitosis: from distinct origins to distinct functions? J. Cell Sci. 125 2012 2805 2814
72. M. Miettinen Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis Mod. Pathol. 27 Suppl 1 2014 S17 S29
73. J. Montero, C. Dutta, D. van Bodegom, D. Weinstock, and A. Letai p53 regulates a non-apoptotic death induced by ROS Cell Death Differ. 20 2013 1465 1474
74. A. Musacchio Spindle assembly checkpoint: the third decade Philos. Trans. R. Soc. Lond. B Biol. Sci. 366 2011 3595 3604
75. A. Musacchio, and E.D. Salmon The spindle-assembly checkpoint in space and time Nat. Rev. Mol. Cell Biol. 8 2007 379 393
76. D. Niewerth, G. Jansen, Y.G. Assaraf, S. Zweegman, G.1 Kaspers, and J. Cloos Molecular basis of resistance to proteasome inhibitors in hematological malignancies Drug Resist. Updat. 18 2015 18 35
77. E.A. Nigg Centrosome aberrations: cause or consequence of cancer progression? Nat. Rev. Cancer 2 2002 815 825
78. M. Nitta, O. Kobayashi, S. Honda, T. Hirota, S. Kuninaka, T. Marumoto, Y. Ushio, and H. Saya Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents Oncogene 23 2004 6548 6558
79. L. Nordström, S. Sernbo, P. Eden, K. Grønbæk, A. Kolstad, R. Räty, M.L. Karjalainen, C. Geisler, E. Ralfkiær, C. Sundström, A. Laurell, J. Delabie, M. Ehinger, M. Jerkeman, and S. Ek SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study Br. J. Haematol. 166 2014 98 108
80. P.C. Nowell, and C.M. Croce Chromosomes, genes, and cancer Am. J. Pathol. 125 1986 7 15
81. K.F. On, Y. Chen, H.T. Ma, J.P.H. Chow, and R.Y.C. Poon Determinants of mitotic catastrophe on abrogation of the G2 DNA damage checkpoint by UCN-01 Mol. Cancer Ther. 10 2011 784 794
82. E.A. Pérès, A.N. Gérault, S. Valable, S. Roussel, J. Toutain, D. Divoux, J.S. Guillamo, M. Sanson, M. Bernaudin, and E. Petit Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe Oncotarget 6 2014 2101 2119
83. S.E. Peterson, Y. Li, F. Wu-Baer, B.T. Chait, R. Baer, H. Yan, M.E. Gottesman, and J. Gautier Activation of DSB processing requires phosphorylation of CtIP by ATR Mol. Cell 49 2013 657 667
84. L. Pikor, K. Thu, E. Vucic, and W. Lam The detection and implication of genome instability in cancer Cancer Metastasis Rev. 32 2013 341 352
85. S.E. Polo, and S.P. Jackson Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications Genes Dev. 25 2011 409 433
86. N.J. Quintyne, J.E. Reing, D.R. Hoffelder, S.M. Gollin, and W.S. Saunders Spindle multipolarity is prevented by centrosomal clustering Science 307 2005 127 129
87. H. Rajagopalan, and C. Lengauer Aneuploidy and cancer Nature 432 2004 338 341
88. C.V. Rao, Y.-M. Yang, M.V. Swamy, T. Liu, Y. Fang, R. Mahmood, M. Jhanwar-Uniyal, and W. Dai Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability Proc. Natl. Acad. Sci. USA 102 2005 4365 4370
89. B. Rebacz, T.O. Larsen, M.H. Clausen, M.H. Rønnest, H. Löffler, A.D. Ho, and A. Krämer Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen Cancer Res. 67 2007 6342 6350
90. I.B. Roninson, E.V. Broude, and B.D. Chang If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells Drug Resist. Updat. 4 2001 303 313
91. K. Rowald, and R. Sotillo Is aneuploidy deciding your fate? Cell Cycle 13 2014 1370
92. B.M. Ryan, N. O'Donovan, and M.J. Duffy Survivin: a new target for anti-cancer therapy Cancer Treat. Rev. 35 2009 553 562
93. B.P. Schlegel, L.M. Starita, and J.D. Parvin Overexpression of a protein fragment of RNA helicase: a causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells Oncogene 22 2003 983 991
94. T.L. Schmit, and N. Ahmad Regulation of mitosis via mitotic kinases: new opportunities for cancer management Mol. Cancer Ther. 6 2007 1920 1931
95. M.W. Schmitt, L.A. Loeb, and J.J. Salk The influence of subclonal resistance mutations on targeted cancer therapy Nat. Rev. Clin. Oncol. 2015 10.1038/nrclinonc.2015.175 [Epub ahead of print]
96. F.S. Shaheen, P. Znojek, A. Fisher, M. Webster, R. Plummer, L. Gaughan, G.C.M. Smith, H.Y. Leung, N.J. Curtin, and C.N. Robson Targeting the DNA double strand break repair machinery in prostate cancer PLoS One 6 2011 203 211
97. A. Sharma, K. Singh, and A. Almasan Histone H2AX phosphorylation: a marker for DNA damage Methods Mol. Biol. 920 2012 613 626
98. R. Shavit, M. Ilouze, T. Feinberg, Y.R. Lawrence, Y. Tzur, and N. Peled Mitochondrial induction as a potential radio-sensitizer in lung cancer cells - a short report Cell. Oncol. (Dordr) 38 2015 247 252
99. S. Sivakumar, and G.J. Gorbsky Spatiotemporal regulation of the anaphase-promoting complex in mitosis Nat. Rev. Mol. Cell Biol. 16 2015 82 94
100. J. Smith, L. Mun Tho, N. Xu, and D.A. Gillespie The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer Adv. Cancer Res. 108 2010 73 112
101. B.D. Solomon, C.E. Turner, D. Klugman, and S.E. Sparks Trisomy 9 mosaicism and XX sex reversal Am. J. Med. Genet. Part A 143 2007 2688 2691
102. R.G. Steinbeck Pathologic mitoses and pathology of mitosis in tumorigenesis Eur. J. Histochem. 45 2001 311 318
103. C. Stevens, L. Smith, and N.B. La Thangue Chk2 activates E2F-1 in response to DNA damage Nat. Cell Biol. 5 2003 401 409
104. Z. Storchova, and C. Kuffer The consequences of tetraploidy and aneuploidy J. Cell Sci. 121 2008 3859 3866
105. Z. Storchova, and D. Pellman From polyploidy to aneuploidy, genome instability and cancer Nat. Rev. Mol. Cell Biol. 5 2004 45 54
106. A. Tighe, V.L. Johnson, and S.S. Taylor Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability J. Cell Sci. 117 2004 6339 6353
107. C.H. Topham, and S.S. Taylor Mitosis and apoptosis: how is the balance set? Curr. Opin. Cell Biol. 25 2013 780 785
108. E.M. Torres, B.R. Williams, and A. Amon Aneuploidy: cells losing their balance Genetics 179 2008 737 746
109. H. Vakifahmetoglu, M. Olsson, C. Tamm, N. Heidari, S. Orrenius, and B. Zhivotovsky DNA damage induces two distinct modes of cell death in ovarian carcinomas Cell Death Differ. 15 2008 555 566
110. H. Vakifahmetoglu-Norberg, and B. Zhivotovsky The unpredictable caspase-2: what can it do? Trends Cell Biol. 20 2010 150 159
111. I. Vitale, L. Galluzzi, M. Castedo, and G. Kroemer Mitotic catastrophe: a mechanism for avoiding genomic instability Nat. Rev. Mol. Cell Biol. 12 2011 385 392
112. K.H. Vousden, and D.P. Lane p53 in health and disease Nat. Rev. Mol. Cell Biol. 8 2007 275 283
113. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat. Rev. Cancer 2 2002 594 604
114. N.A. Wallace, K. Robinson, H.L. Howie, and D.A. Galloway HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage PLoS Pathog. 8 2012 e1002807
115. X. Wang, S. Peralta, and C.T. Moraes Mitochondrial alterations during carcinogenesis. A review of metabolic transformation and targets for anticancer treatments Adv. Cancer Res. 119 2013 127 160
116. A. Waraky, K. Akopyan, V. Parrow, T. Strömberg, L. Abrahmsén, A. Lindqvist, O. Larsson, and E. Aleem Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism Oncotarget 5 2014 8379 8392
117. B.A. Weaver, and D.W. Cleveland The aneuploidy paradox in cell growth and tumorigenesis Cancer Cell 14 2008 3984 3992
118. E. Willmore, S.L. Elliott, T. Mainou-Fowler, G.P. Summerfield, G.H. Jackson, F. O'Neill, C. Lowe, A. Carter, R. Harris, A.R. Pettitt, C. Cano-Soumillac, R.J. Griffin, I.G. Cowell, C.A. Austin, and B.W. Durkacz DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia Clin. Cancer Res. 14 2008 3984 3992
119. S. Xie, H. Wu, Q. Wang, J. Kunicki, R.O. Thomas, R.E. Hollingsworth, J. Cogswell, and W. Dai Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2 Cell Cycle 1 2002 424 429
120. S. Yang, C. Kuo, J.E. Bisi, and M.K. Kim PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2 Nat. Cell Biol. 4 2002 865 870
121. L. Yu, L. Yang, W. An, and X. Su Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells J. Cell. Biochem. 115 2014 697 711
122. T.I. Zack, S.E. Schumacher, S.L. Carter, A.D. Cherniack, G. Saksena, B. Tabak, M.S. Lawrence, C.-Z. Zhang, J. Wala, C.H. Mermel, C. Sougnez, S.B. Gabriel, B. Hernandez, H. Shen, P.W. Laird, G. Getz, M. Meyerson, and R. Beroukhim Pan-cancer patterns of somatic copy number alteration Nat. Genet. 45 2013 1134 1140
123. B. Zhivotovsky, and S. Orrenius Cell cycle and cell death in disease: past, present and future J. Intern. Med. 268 2010 395 409
124. J. Zimmet, and K. Ravid Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system Exp. Hematol. 28 2000 3 16